Cargando…

Different rectal toxicity tolerance with and without simultaneous conventionally-fractionated pelvic lymph node treatment in patients receiving hypofractionated prostate radiotherapy

PURPOSE: To investigate added morbidity associated with the addition of pelvic elective nodal irradiation (ENI) to hypofractionated radiotherapy to the prostate. METHODS AND MATERIALS: Two-hundred twelve patients, treated with hypofractionated radiotherapy to the prostate between 2004 and 2011, met...

Descripción completa

Detalles Bibliográficos
Autores principales:	McDonald, Andrew M, Baker, Christopher B, Popple, Richard A, Shekar, Kiran, Yang, Eddy S, Jacob, Rojymon, Cardan, Rex, Kim, Robert Y, Fiveash, John B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060093/ https://www.ncbi.nlm.nih.gov/pubmed/24893842 http://dx.doi.org/10.1186/1748-717X-9-129

Ejemplares similares

Feasibility of Dose Escalating [(18)F]fluciclovine Positron Emission Tomography Positive Pelvic Lymph Nodes During Moderately Hypofractionated Radiation Therapy for High-Risk Prostate Cancer
por: McDonald, Andrew M., et al.
Publicado: (2019)

Prostate Stereotactic Body Radiation Therapy With a Focal Simultaneous Integrated Boost: Acute Toxicity and Dosimetry Results From a Prospective Trial
por: McDonald, Andrew M., et al.
Publicado: (2018)

Pelvic Radiotherapy versus Radical Prostatectomy with Limited Lymph Node Sampling for High-Grade Prostate Adenocarcinoma
por: Baker, Christopher B., et al.
Publicado: (2016)

Hypofractionated Prostate Radiotherapy with or without Conventionally Fractionated Nodal Irradiation: Clinical Toxicity Observations and Retrospective Daily Dosimetry
por: McDonald, Andrew M., et al.
Publicado: (2012)

A Holographic Augmented Reality Guidance System for Patient Alignment: A Feasibility Study
por: Cardan, Rex, et al.
Publicado: (2021)

Stereotactic radiosurgery with MLC‐defined arcs: Verification of dosimetry, spatial accuracy, and end‐to‐end tests
por: Brezovich, Ivan A., et al.
Publicado: (2019)

Technical Note: An open source solution for improving TG‐263 compliance
por: Cardan, Rex A., et al.
Publicado: (2019)

Technical Note: Use of automation to eliminate shift errors
por: Covington, Elizabeth L., et al.
Publicado: (2020)

Code Wisely: Risk assessment and mitigation for custom clinical software
por: Cardan, Rex A., et al.
Publicado: (2021)

The Role of Simultaneous Integrated Boost in Locally Advanced Rectal Cancer Patients with Positive Lateral Pelvic Lymph Nodes
por: Meldolesi, Elisa, et al.
Publicado: (2022)

Accuracy of dose‐volume metric calculation for small‐volume radiosurgery targets
por: Stanley, Dennis N., et al.
Publicado: (2021)

Optimal Planning Target Volume Margins for Elective Pelvic Lymphatic Radiotherapy in High-Risk Prostate Cancer Patients
por: Hinton, Benjamin K., et al.
Publicado: (2013)

Hypofractionated helical intensity-modulated radiotherapy of the prostate bed after prostatectomy with or without the pelvic lymph nodes - the PRIAMOS trial
por: Krause, Sonja, et al.
Publicado: (2012)

Lateral pelvic lymph nodes for rectal cancer: A review of diagnosis and management
por: Ogawa, Shimpei, et al.
Publicado: (2021)

Improving Communication of Peer-Review Conference Outcomes: A Practical Experience
por: Jones, Joseph A., et al.
Publicado: (2023)

Assessing the feasibility of single target radiosurgery quality assurance with portal dosimetry
por: Covington, Elizabeth L., et al.
Publicado: (2019)

Prophylactic lateral pelvic lymph node dissection in stage IV low rectal cancer
por: Tamura, Hiroshi, et al.
Publicado: (2017)

Long-Term Results of Postoperative Hypofractionated Accelerated Breast and Lymph Node Radiotherapy (HypoAR) with Hypofractionated Boost
por: Koukourakis, Ioannis M., et al.
Publicado: (2021)

The in-silico feasibility of dose escalated, hypofractionated radiotherapy for rectal cancer
por: Devlin, Lynsey, et al.
Publicado: (2022)

Automated evaluation for rapid implementation of knowledge‐based radiotherapy planning models
por: Harms, Joseph, et al.
Publicado: (2023)

Utility of the sentinel node concept for detection of lateral pelvic lymph node metastasis in lower rectal cancer
por: Yanagita, Shigehiro, et al.
Publicado: (2017)

Prognostic significance of lateral pelvic lymph node dissection for middle-low rectal cancer patients with lateral pelvic lymph node metastasis: a propensity score matching study
por: Zhou, Sicheng, et al.
Publicado: (2022)

Efficacy of hypofractionated preoperative chemoradiotherapy in rectal cancer
por: Cho, Ick Joon, et al.
Publicado: (2023)

Minimally Invasive Techniques for an Intersphincteric Resection and Lateral Pelvic Lymph Node Dissection in Rectal Cancer
por: Huh, Jung Wook
Publicado: (2014)

Initial Clinical Experience with Robotic Lateral Pelvic Lymph Node Dissection for Advanced Rectal Cancer
por: Park, Ju-A, et al.
Publicado: (2012)

Optimal treatment strategies for clinically suspicious lateral pelvic lymph node metastasis in rectal cancer
por: Kim, Hye Jin, et al.
Publicado: (2017)

Controversies in the Management of Lateral Pelvic Lymph Nodes in Patients With Advanced Rectal Cancer: East or West?
por: Otero de Pablos, Jaime, et al.
Publicado: (2020)

Computed tomography texture analysis for the prediction of lateral pelvic lymph node metastasis of rectal cancer
por: Nakao, Toshihiro, et al.
Publicado: (2022)

Simultaneous Integrated Boost Intensity-Modulated Radiation Therapy Can Benefit the Locally Advanced Rectal Cancer Patients With Clinically Positive Lateral Pelvic Lymph Node
por: Li, Shuai, et al.
Publicado: (2021)

Comparison of peripheral leukocyte parameters in patients receiving conventionally and hypofractionated radiotherapy schemes for the treatment of newly diagnosed glioblastoma
por: Greenlund, Lindsey, et al.
Publicado: (2023)

Lateral pelvic lymph node dissection and radiation treatment for rectal cancer: Mutually exclusive or mutually beneficial?
por: Sammour, Tarik, et al.
Publicado: (2018)

Corrigendum: Controversies in the Management of Lateral Pelvic Lymph Nodes in Patients With Advanced Rectal Cancer: East or West?
por: Otero de Pablos, Jaime, et al.
Publicado: (2020)

Corrigendum: Simultaneous Integrated Boost Intensity-Modulated Radiation Therapy Can Benefit the Locally Advanced Rectal Cancer Patients with Clinically Positive Lateral Pelvic Lymph Node
por: Li, Shuai, et al.
Publicado: (2021)

Moderately Hypofractionated Radiotherapy with Simultaneous Integrated Boost in Prostate Cancer: A Comparative Study with Conventionally Fractionated Radiation
por: Cante, Domenico, et al.
Publicado: (2020)

MR imaging of pelvic lymph nodes
por: Barentsz, Jelle
Publicado: (2015)

Conversion and validation of rectal constraints for prostate carcinoma receiving hypofractionated carbon-ion radiotherapy with a local effect model
por: Wang, Weiwei, et al.
Publicado: (2021)

Risk factors and prognostic significance of lateral pelvic lymph node dissection after neoadjuvant chemoradiotherapy for rectal patients with clinically suspected lateral lymph node metastasis
por: Zhou, Sicheng, et al.
Publicado: (2021)

Robotic and laparoscopic pelvic lymph node dissection for rectal cancer: short-term outcomes of 21 consecutive series
por: Bae, Sung Uk, et al.
Publicado: (2014)

Treating patients with advanced rectal cancer and lateral pelvic lymph nodes with preoperative chemoradiotherapy based on pretreatment imaging
por: Otowa, Yasunori, et al.
Publicado: (2015)

Complete Response of Para-Aortic and Lateral Pelvic Lymph Node Recurrence of Rectal Cancer Treated to S-1 Monotherapy
por: Miyazawa, Tomonori, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_386d8s161nk0lnlj2ucldprsl1